Hep C Reinfection Observed in HIV-Positive Men Who Have Sex With Men
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 8, 2024 -- The incidence rate of hepatitis C virus (HCV) reinfection was 4.7 per 100 person-years among men who have sex with men (MSM) with HIV who cleared HCV, according to a study published online July 18 in Clinical Infectious Diseases.
Daniel S. Fierer, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues conducted a prospective cohort study involving MSM with HIV who cleared HCV to examine the incidence of and risk factors for HCV reinfection. The risk behaviors for primary HCV were assessed in New York City, including receipt of semen into the rectum and sexualized methamphetamine use, along with route of use.
The researchers found that 42 reinfections occurred over 898 person-years among 304 MSM with HIV who cleared HCV from 2000 through 2018, for an incidence rate of 4.7 per 100 person-years. Assessing 1,245 postclearance visits, there was only an association for receipt of semen into the rectum with reinfection (hazard ratio, 9.7), but no association was seen for methamphetamine use.
"We found the HCV reinfection rate to be an order of magnitude higher than the primary infection rate, similar to the findings from other cohorts in other countries," the authors write. "Condom use, the most effective currently available intervention to prevent semen ejaculation into the rectum, has not been successful as an HCV prevention strategy. Our results therefore suggest the need for novel interventions to prevent sexual transmission of HCV among MSM."
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...
Guidelines Updated for Nonoccupational Postexposure Prophylaxis for HIV
FRIDAY, May 9, 2025 -- Updated recommendations for antiretroviral nonoccupational postexposure prophylaxis (nPEP) for HIV have been published in the May 8 issue of the U.S...
Urticaria Reported in Trial of Investigational HIV mRNA Vaccines
MONDAY, May 5, 2025 -- Urticaria is seen in association with experimental HIV-1 mRNA vaccination, according to a study published online April 29 in the Annals of Internal...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.